Genetic Analysis of CYP1B1 and Other Anterior Segment Dysgenesis-Associated Genes in Latvian Cohort of Primary Congenital Glaucoma

<b>Background</b>: Primary congenital glaucoma (PCG) is a rare disease with an incidence of 1 in 12,000 to 18,000 in Europeans. The scarcity of the disease and limited access to genetic testing have hindered research, particularly within the Latvian population. <b>Objectives</b>: This study aims to present the preliminary results of a molecular genetic investigation into PCG in a Latvian cohort and to compare the prevalence of gene <i>CYP1B1</i> variants with other European studies as well as to the general population in Latvia. <b>Methods</b>: Twenty probands with clinically diagnosed PCG and 36 family members enrolled in the study. Genetic testing was conducted using genomic DNA from peripheral blood using next generation sequencing (NGS) of seven selected genes: <i>CYP1B1, FOXC1, FOXE3, PXDN, PITX2, PITX3, PAX6</i>, and <i>CPAMD8</i>. Four probands had whole-genome sequencing (WGS). <b>Results</b>: All participants were of European ancestry, with no family history of PCG. Most probands were diagnosed in their first year of life, with a female to male ratio of 1:1.2 and with 80.0% of cases being unilateral. No <i>CYP1B1</i> pathogenic variants were identified in the screened subjects. However, a heterozygous missense variant c.4357C>A (p.Pro4357Thr) in the <i>PXDN</i> gene was found in one proband and one of her parents that was classified as a variant of uncertain significance. <b>Conclusions</b>: This study represents the first genetic characterization of PCG in the Latvian population. Using NGS, we identified no pathogenic variants in the <i>CYP1B1</i> gene among affected individuals. Preliminary evidence from this cohort does not support <i>CYP1B1</i> variants as a predominant cause of PCG, though larger studies are needed to confirm this observation. Comprehensive genetic screening using whole-exome or whole-genome sequencing will be essential to identify the underlying genetic etiology of PCG in Latvia.

Authors

Institutions

Publication Details

Journal
Biomedicines
Published
2025-05-18
DOI
https://doi.org/10.3390/biomedicines13051222
Citations
1
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
1.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genetic Analysis of CYP1B1 and Other Anterior Segment Dysgenesis-Associated Genes in Latvian Cohort of Primary Congenital Glaucoma

Pawel Zayakin, Baiba Lāce, Eva Elksne, Inna Inashkina et al.
1 citations
Biomedicines
Glaucoma and retinal disorders
1.71
article

Genetic Analysis of CYP1B1 and Other Anterior Segment Dysgenesis-Associated Genes in Latvian Cohort of Primary Congenital Glaucoma

Pawel Zayakin, Baiba Lāce, Eva Elksne, Inna Inashkina, Ieva Mičule, Ēriks Elksnis, Janis Stavusis, Artūrs Ozoliņš, Sandra Valeiņa, Anastasija Tvoronovica
article en
1 citations

Abstract

<b>Background</b>: Primary congenital glaucoma (PCG) is a rare disease with an incidence of 1 in 12,000 to 18,000 in Europeans. The scarcity of the disease and limited access to genetic testing have hindered research, particularly within the Latvian population. <b>Objectives</b>: This study aims to present the preliminary results of a molecular genetic investigation into PCG in a Latvian cohort and to compare the prevalence of gene <i>CYP1B1</i> variants with other European studies as well as to the general population in Latvia. <b>Methods</b>: Twenty probands with clinically diagnosed PCG and 36 family members enrolled in the study. Genetic testing was conducted using genomic DNA from peripheral blood using next generation sequencing (NGS) of seven selected genes: <i>CYP1B1, FOXC1, FOXE3, PXDN, PITX2, PITX3, PAX6</i>, and <i>CPAMD8</i>. Four probands had whole-genome sequencing (WGS). <b>Results</b>: All participants were of European ancestry, with no family history of PCG. Most probands were diagnosed in their first year of life, with a female to male ratio of 1:1.2 and with 80.0% of cases being unilateral. No <i>CYP1B1</i> pathogenic variants were identified in the screened subjects. However, a heterozygous missense variant c.4357C>A (p.Pro4357Thr) in the <i>PXDN</i> gene was found in one proband and one of her parents that was classified as a variant of uncertain significance. <b>Conclusions</b>: This study represents the first genetic characterization of PCG in the Latvian population. Using NGS, we identified no pathogenic variants in the <i>CYP1B1</i> gene among affected individuals. Preliminary evidence from this cohort does not support <i>CYP1B1</i> variants as a predominant cause of PCG, though larger studies are needed to confirm this observation. Comprehensive genetic screening using whole-exome or whole-genome sequencing will be essential to identify the underlying genetic etiology of PCG in Latvia.

BiomedicinesVol. 13(5)
Latvian Biomedical Research and Study Centre (LV), Riga East University Hospital (LV), Pauls Stradiņš Clinical University Hospital (LV), Children's Clinical University Hospital (LV), Riga Stradiņš University (LV)
European Regional Development Fund
Good health and well-being
Openalex Percentile: Top 18%
Glaucoma and retinal disorders
1.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.